Elicio Therapeutics logo

Elicio Therapeutics Share Price Today

(NASDAQ: ELTX)

Elicio Therapeutics share price is $8.27 & ₹719.23 as on 6 Mar 2025, 2.30 'hrs' IST

$8.27

0.09

(1.1%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Elicio Therapeutics share price in Dollar and Rupees. Guide to invest in Elicio Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Elicio Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Elicio Therapeutics share price movements

  • Today's Low: $8.10
    Today's High: $8.35

    Day's Volatility :3.05%

  • 52 Weeks Low: $3.34
    52 Weeks High: $11.45

    52 Weeks Volatility :70.81%

Elicio Therapeutics (ELTX) Returns

Period Elicio Therapeutics IncIndex (Russel 2000)
3 Months
70.06%
0.0%
6 Months
105.01%
0.0%
1 Year
97.58%
0.0%
3 Years
339.78%
-11.6%

Elicio Therapeutics (ELTX) Key Statistics

in dollars & INR

Previous Close
$8.18
Open
$8.27
Today's High
$8.35
Today's Low
$8.095
Market Capitalization
$94.5M
Today's Volume
$1.8K
52 Week High
$11.45
52 Week Low
$3.3419
Revenue TTM
$0.0
EBITDA
$-40.6M
Earnings Per Share (EPS)
$-3.53
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-353.02%

How to invest in Elicio Therapeutics Stock (ELTX) from India?

It is very easy for Indian residents to invest directly in Elicio Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Elicio Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Elicio Therapeutics or ELTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Elicio Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Elicio Therapeutics shares which would translate to 0.105 fractional shares of Elicio Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Elicio Therapeutics, in just a few clicks!

Returns in Elicio Therapeutics (ELTX) for Indian investors in Rupees

The Elicio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Elicio Therapeutics investment value today

Current value as on today

₹2,04,721

Returns

₹1,04,721

(+104.72%)

Returns from Elicio Therapeutics Stock

₹99,758 (+99.76%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Elicio Therapeutics (ELTX)

-36%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Elicio Therapeutics Stock from India on INDmoney has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Elicio Therapeutics

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Elicio Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Elicio Therapeutics Stock (ELTX)

What analysts predicted

Upside of 8.83%

Target:

$9.00

Current:

$8.27

Insights on Elicio Therapeutics Stock (Ticker Symbol: ELTX)

  • Price Movement

    In the last 3 months, ELTX stock has moved up by 70.1%

Elicio Therapeutics Technicals Summary

Sell

Neutral

Buy

Elicio Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Elicio Therapeutics (ELTX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
 Elicio Therapeutics Inc logo
-8.3%
105.01%
97.58%
339.78%
-51.94%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
 Elicio Therapeutics Inc logo
5.75
NA
NA
-4.07
-3.53
-0.74
NA
-1.76
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
 Elicio Therapeutics Inc logo
Buy
$94.5M
-51.94%
5.75
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Elicio Therapeutics

Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted AMP peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company is also developing ELI-007, a multivalent lymph node"targeted AMP peptide vaccine to target mutant v-raf murine sarcoma viral oncogene homolog B1 gene mutations found in solid tumors; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine to target p53 hotspot mutations. The company is headquartered in Boston, Massachusetts.
Organization
Elicio Therapeutics
Employees
32
CEO
Mr. Robert T. Connelly
Industry
Miscellaneous

Management People of Elicio Therapeutics

NameTitle
Mr. Robert T. Connelly
CEO, President, Principal Accounting Officer, Principal Financial Officer & Director
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.
Founder & Independent Director
Dr. Christopher M. Haqq M.D., Ph.D.
Executive VP, Head of Research & Development and Chief Medical Officer
Dr. Darrell J. Irvine Ph.D.
Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Mr. Michael DiVecchia
Senior Vice President of Operations & Human Resources
Dr. Peter DeMuth Ph.D.
Chief Scientific Officer
Ms. Megan C. Filoon
General Counsel, Secretary & Compliance Officer
Ms. Esther Welkowsky
Senior Vice President of Clinical Development
Ms. Joy Seymour
VP & Head of Regulatory Affairs
Dr. Thian Kheoh Ph.D.
Senior Vice President of Biometrics

Important FAQs about investing in ELTX Stock from India :

What is Elicio Therapeutics share price today?

Elicio Therapeutics share price today stands at $8.27, Open: $8.27 ; Previous Close: $8.18 ; High: $8.35 ; Low: $8.10 ; 52 Week High: $11.45 ; 52 Week Low: $3.34.

The stock opens at $8.27, after a previous close of $8.18. The stock reached a daily high of $8.35 and a low of $8.10, with a 52-week high of $11.45 and a 52-week low of $3.34.

Can Indians buy Elicio Therapeutics shares?

Yes, Indians can invest in the Elicio Therapeutics (ELTX) from India.

With INDmoney, you can buy Elicio Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Elicio Therapeutics at zero transaction cost.

How can I buy Elicio Therapeutics shares from India?

It is very easy to buy Elicio Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Elicio Therapeutics (ELTX) be purchased?

Yes, you can buy fractional shares of Elicio Therapeutics with INDmoney app.

What are the documents required to start investing in Elicio Therapeutics stocks?

To start investing in Elicio Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Elicio Therapeutics Stock (ELTX)?

Today’s highest price of Elicio Therapeutics (ELTX) is $8.35.

Today’s lowest price of Elicio Therapeutics (ELTX) is $8.10.

What is today's market capitalisation of Elicio Therapeutics?

Today's market capitalisation of Elicio Therapeutics ELTX is 94.5M

What is the 52 Week High and Low Range of Elicio Therapeutics Stock (ELTX)?

  • 52 Week High

    $11.45

  • 52 Week Low

    $3.34

What are the historical returns of Elicio Therapeutics (ELTX)?

  • 1 Month Returns

    -8.3%

  • 3 Months Returns

    105.01%

  • 1 Year Returns

    97.58%

  • 5 Years Returns

    -51.94%

Who is the Chief Executive Officer (CEO) of Elicio Therapeutics ?

Mr. Robert T. Connelly is the current Chief Executive Officer (CEO) of Elicio Therapeutics.